Evidence map›Paper›PMID 42376069›Full record

ArticleFEMS microbes2026

Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant

Nagendra N Mishra, Cody A Black, Wessam Abdelhady, Sabrina Farah, Naidelyn A Rodas, Josue Brizuela, Clarissa Bustamante Lopez, Jorge N Artaza, George Sakoulas, Warren E Rose

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FEMS microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nagendra N MishraDivision of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, United States.ORCID https://orcid.org/0000-0002-7475-5794
Cody A BlackCollege of Pharmacy, The University of Texas at Austin, Austin, TX 78712, United States.
Wessam AbdelhadyDavid Geffen School of Medicine, University of California, Los Angeles (UCLA), CA 90095, United States.
Sabrina FarahDavid Geffen School of Medicine, University of California, Los Angeles (UCLA), CA 90095, United States.
Naidelyn A RodasDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, United States.
Josue BrizuelaDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, United States.
Clarissa Bustamante LopezDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, United States.
Jorge N ArtazaDepartment of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, United States.
George SakoulasDivision of Host-Microbe Systems and Therapeutics, University of California San Diego, School of Medicine, La Jolla, CA, United States.
Warren E RoseSchool of Pharmacy, University of Wisconsin-Madison, WI 53705, United States.ORCID https://orcid.org/0000-0001-5012-5993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent

Indexed as

ceftarolinedaptomycingeneticsmechanismsMSSAresistance

Identifiers

PMID42376069
PMCPMC13312282

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.